Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Kidney International

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.2001.060003969.XPMID 11532091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy.

  1999cited by this paper
• Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.

  1999cited by this paper
• Structural features of IgA molecules which contribute to IgA nephropathy.

  1999cited by this paper
• Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

  1999cited by this paper
• Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins.

  1998cited by this paper
• Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.

  1998cited by this paper
• Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  1998cited by this paper
• Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.

  1997cited by this paper
• Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy.

  1997cited by this paper
• Association of asialo-galactosyl beta 1-3N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy.

  1996cited by this paper
• Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy

  1995cited by this paper
• Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

  1993cited by this paper
• Serum IgA and macromolecular IgA reacting with mesangial matrix components.

  1993cited by this paper
• The structure and function of human IgA.

  1990cited by this paper
• O-linked oligosaccharides from human serum immunoglobulin A1.

  1989cited by this paper
• Charge and size of mesangial IgA in IgA nephropathy.

  1985cited by this paper

• Glomerular Galactose‐Deficient IgA1 Deposition in 192 Autopsy Cases in Japan

  2025cites this paper
• Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.

  2025cites this paper
• B Cell Activating Factor Does Not Play a Pivotal Role in the Synthesis of Aberrantly Glycosylated IgA

  2025cites this paper
• Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis.

  2025cites this paper
• Differential Cell-Specific, Regulatory Roles of FcγRIIB through IgG in IgA Nephropathy.

  2025cites this paper
• Origin of poorly galactosylated IgA1 other than mucosa: a viewpoint from a report on patient with IgA vasculitis

  2025cites this paper
• Proteomic Analysis of Circulating IgA1-Containing Immune Complexes in Patients with IgA Nephropathy

  2025cites this paper
• New thoughts on the intestinal microbiome-B cell-IgA axis and therapies in IgA nephropathy.

  2025cites this paper
• Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy.

  2025cites this paper
• Targeting APRIL in the treatment of glomerular diseases.

  2024cites this paper
• O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

  2024cites this paper
• Diagnosing and Treating IgAN: Steroids, Budesonide, or Maybe Both?

  2024cites this paper
• Lessons from IgA Nephropathy Models

  2024cites this paper
• The pathogenesis of IgA nephropathy and implications for treatment

  2024cites this paper
• Pathogenesis of IgA nephropathy as a tissue-specific autoimmune disease.

  2024cites this paper
• The pathogenesis of IgAN: Where is pathogenic IgA produced?

  2024cites this paper
• Pathogenesis of IgA nephropathy: Omics data inform glycomedicine

  2024cites this paper
• Links between oropharyngeal microbiota and IgA nephropathy: A paradigm shift from isolated microbe to microbiome.

  2024cites this paper
• Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy

  2024cites this paper
• Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy

  2024cites this paper
• Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy

  2023influential citation
• Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy

  2023cites this paper
• IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease

  2023cites this paper
• Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores

  2023cites this paper
• Role of tumor cell sialylation in pancreatic cancer progression.

  2023cites this paper
• Drusen and other retinal findings in people with IgA glomerulonephritis.

  2023cites this paper
• Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

  2023cites this paper
• IL-6 and its role in IgA nephropathy development.

  2022cites this paper
• The Glomerulus According to the Mesangium

  2022cites this paper
• Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy

  2022cites this paper
• Simultaneous Presence of Campylobacter rectus and Cnm-Positive Streptococcus mutans in the Oral Cavity Is Associated with Renal Dysfunction in IgA Nephropathy Patients: 5-Year Follow-Up Analysis

  2022cites this paper
• IgA nephropathy: an overview of drug treatments in clinical trials

  2022cites this paper
• New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid

  2022cites this paper
• Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study

  2022cites this paper
• Development and Evaluation of a Robust Sandwich Immunoassay System Detecting Serum WFA-Reactive IgA1 for Diagnosis of IgA Nephropathy

  2022cites this paper
• Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy

  2022cites this paper
• Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?

  2022cites this paper
• Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement

  2022cites this paper
• Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy

  2022cites this paper
• Title IgA Nephropathy and Oral Bacterial Species Related to Dental Caries and Periodontitis

  2022cites this paper
• Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy

  2022cites this paper
• The New Progress of Treatment in IgA Nephropathy

  2022cites this paper
• Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy

  2022cites this paper
• Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

  2021cites this paper
• Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.

  2021cites this paper
• An Update on the Current State of Management and Clinical Trials for IgA Nephropathy

  2021cites this paper
• Immunological drivers of IgA nephropathy: Exploring the mucosa–kidney link

  2021cites this paper
• Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy

  2021cites this paper
• Immune Characteristics of IgA Nephropathy With Minimal Change Disease

  2021cites this paper
• Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy.

  2021cites this paper
• Fantastic IgA plasma cells and where to find them

  2021cites this paper
• IgA vasculitis with nephritis: update of pathogenesis with clinical implications

  2021cites this paper
• Tonsillectomy Combined With Steroid Pulse Therapy Prevents the Progression of Chronic Kidney Disease in Patients With Immunoglobulin A (IgA) Nephropathy in a Single Japanese Institution

  2021cites this paper
• Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy

  2021cites this paper
• Quantitative assessment of successive carbohydrate additions to the clustered O -glycosylation sites of IgA1 by glycosyltransferases

  2021cites this paper
• IgA Nephropathy: A Chinese Perspective

  2021cites this paper
• IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment

  2021cites this paper
• Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment

  2021cites this paper
• The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group

  2021cites this paper
• New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy

  2021cites this paper
• IgA glycosylation and immune complex formation in IgAN

  2021cites this paper
• SOLUBLE CD89 IS A CRITICAL FACTOR FOR MESANGIAL PROLIFERATION IN CHILDHOOD IgA NEPHROPATHY.

  2021cites this paper
• Precision medicine in immunoglobulin A nephropathy: still a journey ahead.

  2021cites this paper
• The Wanderings of Gut-Derived IgA Plasma Cells: Impact on Systemic Immune Responses

  2021cites this paper
• Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know

  2021cites this paper
• Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy

  2020cites this paper
• IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

  2020cites this paper
• Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies

  2020cites this paper
• Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy

  2020cites this paper
• Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins

  2020cites this paper
• IgA nephropathy associated with axial spondyloarthritis responding to treatment by etanercept: A case report

  2020cites this paper
• LC-MS methods analyzing clustered O-glycosylation reactions.

  2020cites this paper
• Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function.

  2020cites this paper
• Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation

  2020cites this paper
• Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy.

  2020cites this paper
• Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases

  2020cites this paper
• 5 IgA Nephropathy : Insights into Genetic Basis and Treatment Options

  2019cites this paper
• The role of complement in IgA nephropathy.

  2019cites this paper
• Particularités cliniques et physiopathologiques de l’atteinte articulaire au cours de la vascularite à IgA chez l’adulte : étude de deux cohortes françaises

  2019cites this paper
• The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy

  2019cites this paper
• A New Vision of IgA Nephropathy: The Missing Link

  2019cites this paper
• Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

  2019cites this paper
• Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.

  2019cites this paper
• The Role Of Kca3.1 In IGA Nephropathy

  2019cites this paper
• TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.

  2019cites this paper
• Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

  2018cites this paper
• Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report

  2018cites this paper
• Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis

  2018cites this paper
• Murine Models of Human IgA Nephropathy.

  2018cites this paper
• IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.

  2018cites this paper
• IgA nephropathy: toward more specific diagnosis (and rescue of snails).

  2018cites this paper
• 15th International Symposium on IgA Nephropathy – IIgANN 2018, Buenos Aires, September 27-29, 2018: Summaries

  2018cites this paper
• Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy

  2018cites this paper
• Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy

  2018cites this paper
• Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases

  2018cites this paper
• Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort

  2018cites this paper
• Glomérulonéphrite primitive à dépôts mésangiaux d’immunoglobulines A

  2018cites this paper
• Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients

  2018cites this paper
• Campylobacter rectus in the Oral Cavity Correlates with Proteinuria in Immunoglobulin A Nephropathy Patients

  2018cites this paper
• Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy

  2018cites this paper